The popularity of Sildenafil initially sparked a boom for pharma, however recent developments present a murky scenario for those considering a stake. Off-patent competitors are eating into earnings, and ongoing patent https://harmonyyihx575881.losblogos.com/39936923/sildenafil-and-big-pharma-a-volatile-bet